retatrutide phase 2 results 2024 2025 Availability & Timeline Retatrutide study sees significant weight

Retatrutide has no equivalent cardiovascular outcomes data

This approach helps improve tolerability while allowing the body to adjust

Established HGH adverse effects: Licensed somatropin SmPCs document a range of recognised adverse effects, including arthralgia, myalgia, peripheral oedema, carpal tunnel syndrome, paraesthesia, and headache

injection of insulin (Humalog, Eli Lilly) at 0.5 IU/kg body weight was administered to mice

Mazdutide is a dual agonist showing strong efficacy, excellent tolerability, and notable improvements in metabolic health

Weeks 1 through 6: 2mg weekly Same starting dose as the standard schedule, but with two extra weeks of adaptation